With Mirko von Hein and The Pharma Perspective. Harvard professor Jerry Avorn and I discuss drug regulation, FDA approval standards, surrogate endpoints, pharmaceutical pricing, public research funding, medical misinformation, and what all of this means for patients, innovation, and health policy.

Harlan Krumholz & Howard Forman, Yale Medical School | Health & Veritas Podcast. In a Wide-Ranging Interview, Dr. Jerry Avorn Explains How the Drug Marketing Machine Works — and How to Counter It Source: Health & Veritas, Yale School of Management, Episode 195, November 13, 2025 In a November 2025 episode of Health & Veritas — the Yale School of Management podcast hosted by physicians Howard Forman and Harlan Krumholz — Jerry Avorn, MD, sat down for an extended conversation c

From American Society for Pharmacy Law (ASPL). In this special edition premiere of Post Scrip, host Henry sits down with Dr. Jerry Avorn, MD, Harvard Medical School professor and author of the groundbreaking book Rethinking Medications: Truth, Power and the Drugs You Take. Dr. Avorn, a senior internist at Mass General Brigham and author of over 600 papers, takes us on a dive into the complex world of drug approval, pricing, and pharmaceutical policy. This episode explores how

From Science-Based Policy. By David Weinberg. Teaser/Abstract "Rethinking Medications: Truth, Power, and the Drugs You Take by Jerry Avorn presents a critical appraisal of the state of the prescription medications in the United States. It explores the complex relationships among drug companies, regulators, prescribers, academics, and patients. The book is part history of US drug regulation, part critique of the status quo, and finally, a roadmap for a better path forward." S

From Changing Minds Podcast. Teaser/Abstract "How do we stay the course and stay rooted in facts amidst a major disruption impacting the healthcare landscape? 'Godfather' and originator of academic detailing Jerry Avorn joins the show to share his reflections on the current state of healthcare; the history of treatment and medications prior to rigorous study; his new book, Rethinking Medications; the critical importance of treating evidence, facts, and science as our collecti